Analysis and optimization of the cationic lipid component of a lipid/peptide vector formulation for enhanced transfection in vitro and in vivo.
about
Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium.Clinical review: gene-based therapies for ALI/ARDS: where are we now?Enhanced intrapulmonary delivery of anticancer siRNA for lung cancer therapy using cationic ethylphosphocholine-based nanolipoplexes.Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.Lipid chain geometry of C14 glycerol-based lipids: effect on lipoplex structure and transfection.Exploring the correlation between lipid packaging in lipoplexes and their transfection efficacy.
P2860
Analysis and optimization of the cationic lipid component of a lipid/peptide vector formulation for enhanced transfection in vitro and in vivo.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Analysis and optimization of t ...... sfection in vitro and in vivo.
@en
Analysis and optimization of t ...... sfection in vitro and in vivo.
@nl
type
label
Analysis and optimization of t ...... sfection in vitro and in vivo.
@en
Analysis and optimization of t ...... sfection in vitro and in vivo.
@nl
prefLabel
Analysis and optimization of t ...... sfection in vitro and in vivo.
@en
Analysis and optimization of t ...... sfection in vitro and in vivo.
@nl
P2093
P2860
P50
P1476
Analysis and optimization of t ...... nsfection in vitro and in vivo
@en
P2093
Alethea B Tabor
Christopher A Hurley
Danielle M Copeman
John B Wong
M Jayne Lawrence
Marianne Odlyha
Michele Writer
Parviz Ayazi Shamlou
Stephen L Hart
P2860
P304
P356
10.1080/08982100600992500
P577
2006-01-01T00:00:00Z